Project Grant R61DA064788
Award Date 3/15/26
Completion Date 2/28/28
Dollars Obligated $454K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Belmont, MA 02478, USA
Similar Awards
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a Project Grant totaling $193,320 to The McLean Hospital Corporation under the Drug Use and Addiction Research Programs (CFDA 93.279) mechanism for the period March 1, 2026 through February 28, 2031. This Career Development Award (K23) supports Dr. Robyn Ellis's training and research activities to develop expertise as an independent investigator conducting mechanistic clinical trials for co-occurring substance use...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $742,500 Project Grant (R34) to Massachusetts General Hospital on July 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279). This three-year pilot study, concluding June 30, 2028, will develop and test a peer recovery coaching intervention designed to promote tobacco abstinence in individuals with concurrent opioid use disorder and tobacco use disorder (MOUD-TUD). The project will adapt an...
- Federal Grant Award Summary Award Details: Funding Agency: National Institute on Drug Abuse (NIDA) Federal Grant Program: Drug Use and Addiction Research Programs (CFDA 93.279) Award Amount: $193,752 Award Date: April 15, 2025 Project Period: April 15, 2025 – March 31, 2030 Recipient: Boston Medical Center Corporation Products and Services: This K23 Career Development Award supports research and implementation activities focused on promoting positive parenting outcomes for mothers with Opioid...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $197,640 Project Grant to Massachusetts General Hospital (MGH) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective March 1, 2026 through February 28, 2030. This four-year research initiative will deliver clinical outcomes research and health economic analysis examining the integration of infectious disease (ID) care into rapid-access substance use disorder (SUD) bridge clinics. The...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Trustees of Boston University a $193,751 Project Grant effective May 1, 2026, through April 30, 2031, under the Drug Use and Addiction Research Programs (CFDA 93.279). This Career Development Award supports a rigorous training and research plan to develop an independent substance use disorder (SUD) services researcher whose work will advance large-scale improvements in SUD care quality. The award funds...
- Federal Grant Award Summary Partnership To End Addiction received a $453,750 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective March 15, 2026 through February 29, 2028. The award funds development and evaluation of HALO (Helping Affected Loved Ones), an artificial intelligence-powered chatbot designed to deliver evidence-based, real-time support to concerned significant others (CSOs)—primarily...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Massachusetts Medical School a $825,383 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning August 1, 2025, with completion targeted for April 30, 2030. This research project investigates the role of striatal molecular rhythms in sleep disruption and opioid use disorder (OUD), addressing the critical public health challenge of high relapse rates among individuals...
- Federal Grant Award Summary Boston College, through the Harvard Chan School of Public Health Center for Work, Health, and Wellbeing in partnership with the Massachusetts Department of Public Health Bureau of Substance Addiction Services (BSAS), received a $941,917 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 1, 2025, through August 31, 2027. The award supports a cluster-randomized...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Scripps Research Institute a Project Grant of $288,107 under the Drug Use and Addiction Research Programs (CFDA 93.279) for the period July 1, 2025 through June 30, 2030. This predoctoral training grant establishes a comprehensive scientific training program designed to develop the next generation of addiction research leaders. The program employs a mentor mosaic model that integrates expertise across multiple...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Icahn School of Medicine at Mount Sinai a $159,615 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) on July 15, 2025, for research extending through June 30, 2027. This K99/R00 award supports a research initiative titled "Predicting Craving and Relapse Using Neurobehavioral Markers of Goals and Habits in Opioid Use Disorder." The project delivers longitudinal neurobehavioral...